Status:
COMPLETED
Single Ascending Dose Study With BPL-003 in Healthy Subjects
Lead Sponsor:
Beckley Psytech Limited
Conditions:
Pharmacokinetics in Healthy Adults
Eligibility:
All Genders
25-55 years
Phase:
PHASE1
Brief Summary
The study will evaluate safety, tolerability and PK profile of BPL-003 in healthy subjects
Eligibility Criteria
Inclusion
- Medically healthy based on medical records and study specific assessments
Exclusion
- Presence or history of severe adverse reaction to any drug or drug excipient
Key Trial Info
Start Date :
February 14 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 19 2024
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT05347849
Start Date
February 14 2022
End Date
January 19 2024
Last Update
March 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hammersmith Medicines Research
London, United Kingdom